Showing 1 - 2 results of 2 for search 'Shane A. Olwill', query time: 0.02s Refine Results
  1. 1
    Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF.

    Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. by Claire Ward, Diana Kuehn, Roberta E Burden, Julie A Gormley, Thomas J Jaquin, Mihaela Gazdoiu, Donna Small, Roy Bicknell, James A Johnston, Christopher J Scott, Shane A Olwill

    Published 2010-01-01
    Get full text
    Article
  2. 2
    New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016

    New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31stAnnual Meeting of the Society for Immunotherapy of Cancer, 2016 by Prasad S. Adusumilli, Edward Cha, Mark Cornfeld, Thomas Davis, Adi Diab, Thomas W. Dubensky, Elizabeth Evans, Jane L. Grogan, Bryan A. Irving, Rom S. Leidner, Shane A. Olwill, Patrick Soon-Shiong, Frederic Triebel, David Tuck, Adrian Bot, Roger D. Dansey, Charles G. Drake, Gordon J. Freeman, Ramy Ibrahim, Salil Patel, Daniel S. Chen

    Published 2017-06-01
    Get full text
    Article

Search Tools: